The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?

Accelerator ™ Drug Development: Collaborative timeline management drives speed and simplicity in global vaccine trial

Case study

When a global biopharma company set aggressive milestones for a high-stakes Phase III vaccine trial, complexity across geographies, supply chains, and regulatory requirements threatened to delay first patient in (FPI). Through the Accelerator™ Drug Development framework, Thermo Fisher Scientific helped align timelines, resolve quality agreement discrepancies, and streamline execution—enabling five weeks of time savings and on-time startup across more than 170 sites worldwide. Discover how collaborative oversight turned a high-risk timeline into a repeatable success.

Collaborative Timeline Management in Global Vaccine Trial

Additional resources